SARS-CoV-2 variants of concern are associated with lower RT-PCR amplification cycles between January and March 2021 in France.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 14 05 2021
revised: 14 09 2021
accepted: 27 09 2021
pubmed: 4 10 2021
medline: 15 12 2021
entrez: 3 10 2021
Statut: ppublish

Résumé

SARS-CoV-2 variants raise concern regarding the mortality caused by COVID-19 epidemics. We analyse 88,375 cycle amplification (Ct) values from variant-specific RT-PCR tests performed between January 26 and March 13, 2021. We estimate that on March 12, nearly 85% of the infections were caused by the Alpha variant and that its transmission advantage over wild type strains was between 38 and 44%. We also find that tests positive for Alpha and Beta/Gamma variants exhibit significantly lower cycle threshold (Ct) values.

Identifiants

pubmed: 34601145
pii: S1201-9712(21)00784-0
doi: 10.1016/j.ijid.2021.09.076
pmc: PMC8484004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-14

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Benedicte Roquebert (B)

Laboratoire Cerba - 7-11 r de l'Équerre, Saint-Ouen-l'Aumône 95310, France.

Stéphanie Haim-Boukobza (S)

Laboratoire Cerba - 7-11 r de l'Équerre, Saint-Ouen-l'Aumône 95310, France.

Sabine Trombert-Paolantoni (S)

Laboratoire Cerba - 7-11 r de l'Équerre, Saint-Ouen-l'Aumône 95310, France.

Emmanuel Lecorche (E)

Laboratoire Cerba - 7-11 r de l'Équerre, Saint-Ouen-l'Aumône 95310, France.

Laura Verdurme (L)

Laboratoire Cerba - 7-11 r de l'Équerre, Saint-Ouen-l'Aumône 95310, France.

Vincent Foulongne (V)

Laboratoire de Virologie, CHU de Montpellier - 80 av Augustin Fliche, Montpellier 34295, France.

Sonia Burrel (S)

Sorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtriére, Service de Virologie - 47-83 bd de l'Hôpital, Paris 75013, France.

Samuel Alizon (S)

MIVEGEC, Univ. Montpellier, CNRS, IRD - 911 av Agropolis, Montpellier Cedex 5 34394, France.

Mircea T Sofonea (MT)

MIVEGEC, Univ. Montpellier, CNRS, IRD - 911 av Agropolis, Montpellier Cedex 5 34394, France. Electronic address: mircea.sofonea@umontpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH